You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Monoclonal Antibodies

Showing 1 - 25 of 7,894
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Covid-19 Convalescent Plasma and Monoclonal Antibodies Treatment

Recruiting
  • COVID-19 Convalescent Plasma Treatment
    • Strasbourg, France
      Service des Maladies Infectieuses et Tropicales - CHU de Strasbo
    Jun 15, 2023

    Medicare Anti-Aß mAb Coverage With Evidence Development Study

    Recruiting
    • Mild Alzheimer's Disease
    • Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease
    • Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease
    • Baltimore, Maryland
      Centers for Medicare and Medicaid Services
    Sep 21, 2023

    Alzheimer Trial (Lecanemab)

    Not yet recruiting
    • Alzheimer Disease
    • (no location specified)
    Jun 22, 2023

    Clostridium Infection Trial in Paris (Collection of peripheral blood mononuclear cells)

    Completed
    • Clostridium Infection
    • Collection of peripheral blood mononuclear cells
    • Paris, France
      Maladies infectieuses et tropicales, Hôpital Pitié-Salpêtrière
    Oct 3, 2022

    Solid Tumor, Adult Trial in Minneapolis, Hackensack, Houston (FT516, Avelumab, Cyclophosphamide)

    Completed
    • Solid Tumor, Adult
    • Minneapolis, Minnesota
    • +2 more
    Jan 27, 2023

    HIV Trial in South Africa (VRC01.23LS, PGT121.414.LS, PGDM1400LS)

    Not yet recruiting
    • HIV Infections
    • VRC01.23LS
    • +2 more
    • Cape Town, Western Cape, South Africa
    • +7 more
    Jul 24, 2023

    A Real-World Study of Anti-SARS-CoV-2 Monoclonal Antibodies

    Recruiting
    • Immunocompromised Patients
    • Data collection
    • Paris, Ile De France, France
      Assistance Publique - Hôpitaux de Paris (AP-HP) - Cochin Hospita
    Jul 5, 2022

    Headache, Migraine Trial in Chicago, Naperville (Ubrogepant 50 MG [Ubrelvy], Ubrogepant 100 MG [Ubrelvy])

    Not yet recruiting
    • Headache, Migraine
    • Ubrogepant 50 MG [Ubrelvy]
    • Ubrogepant 100 MG [Ubrelvy]
    • Chicago, Illinois
    • +1 more
    Aug 14, 2022

    Against BK Virus Infection Based on Monoclonal Antibodies

    Not yet recruiting
    • BK Virus Infection
      • Strasbourg, France
        Service de Virologie - CHU Strasbourg - France
      Feb 21, 2022

      Allergic Rhinitis, Conjunctivitis Trial (REGN5713, REGN5714, REGN5715)

      Not yet recruiting
      • Allergic Rhinitis
      • Conjunctivitis
      • (no location specified)
      Jun 20, 2022

      Solid Tumor, Adult Trial in United States (FT538, Cyclophosphamide, Fludarabine)

      Recruiting
      • Solid Tumor, Adult
      • Hackensack, New Jersey
      • +3 more
      Apr 14, 2022

      Non Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer Trial in Huntersville (FT536, Cyclophosphamide, Fludarabine)

      Recruiting
      • Non Small Cell Lung Cancer
      • +6 more
      • Scottsdale, Arizona
      • +4 more
      Dec 27, 2022

      Long COVID, Post-Acute Sequela of COVID-19, Post-Acute COVID-19 Trial in San Francisco (AER002, Placebo)

      Not yet recruiting
      • Long COVID
      • +2 more
      • San Francisco, California
        UCSF/Zuckerberg San Francisco General Hospital
      Jun 2, 2023

      Metastatic Colorectal Carcinoma Trial (Pentoxifylline, FOLFOX, XELOX)

      Not yet recruiting
      • Metastatic Colorectal Carcinoma
      • (no location specified)
      Nov 1, 2023

      Neuroblastoma, Ganglioneuroblastoma Trial in Moscow (monoclonal antibodies GD2)

      Recruiting
      • Neuroblastoma
      • Ganglioneuroblastoma
      • monoclonal antibodies GD2
      • Moscow, Russian Federation
        Research Institute of Pediatric Hematology, Oncology and Immunol
      Oct 4, 2023

      Coronavirus Infections Trial in Moscow (tixagevimab/cilgavimab 150+150 mg, tixagevimab/cilgavimab 300+300 mg, regdanvimab)

      Active, not recruiting
      • Coronavirus Infections
      • tixagevimab/cilgavimab 150+150 mg
      • +2 more
      • Moscow, Russian Federation
        Moscow City Clinical Hospital 52
      Aug 7, 2023

      Healthy, Chronic Stable Illness Trial in Miami, Winter Park (Casirivimab+Imdevimab)

      Completed
      • Healthy
      • Chronic Stable Illness
      • Miami, Florida
      • +1 more
      Jun 15, 2022

      Acquiring Convalescent Specimens for COVID-19 Antibodies

      Completed
      • COVID-19
      • +2 more
      • Blood draw
      • New York, New York
        Columbia University Irving Medical Center/NYP
      Jul 18, 2022

      COVID-19 Trial in Hong Kong (BRII-196 and BRII-198, Placebo)

      Withdrawn
      • COVID-19
      • BRII-196 and BRII-198
      • Placebo
      • Hong Kong, China
        Investigative Site 1
      Mar 1, 2022

      Monoclonal Antibodies (Sotrovimab )

      Recruiting
      • COVID-19 Respiratory Infection
        • Dubai, United Arab Emirates
          Emirats Health Service
        Dec 13, 2021

        COVID-19 Trial in Beijing (BRII-196 and BRII-198, Placebo)

        Completed
        • COVID-19
        • BRII-196 and BRII-198
        • Placebo
        • Beijing, Beijing, China
          Investigative Site
        Mar 1, 2022

        SURvival of SEzary Syndrome Over 1998-2020 Period and Its

        Not yet recruiting
        • Sezary Syndrome
        • Cutaneous T Lymphoma
        • Standard of care
        • Paris, France
          Hôpital Saint-Louis, Service de Dermatologie
        Jan 24, 2022

        Covid19 Trial in Edinburg, Rio Grande City (BAMLANIVIMAB, CASIRIVIMAB, IMDEVIMAB)

        Recruiting
        • Covid19
        • BAMLANIVIMAB
        • +2 more
        • Edinburg, Texas
        • +2 more
        Mar 14, 2022

        COVID-19 Trial (GamCoviMab)

        Not yet recruiting
        • COVID-19
        • (no location specified)
        Feb 6, 2023

        COVID-19 Trial in Stony Brook, Memphis (casirivimab+imdevimab)

        Terminated
        • COVID-19
        • Stony Brook, New York
        • +1 more
        Jul 26, 2022